Paper30203151
Targeting HMGB1/TLR4 axis and miR-21 by rosuvastatin: role in alleviating cholestatic liver injury in a rat model of bile duct ligation.
Nabih ES and 1 other. Naunyn Schmiedebergs Arch Pharmacol, 2019. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Targeting HMGB1/TLR4 axis and miR-21 by rosuvastatin: role in alleviating cholestatic liver injury in a rat model of bile duct ligation. Papers, record 30203151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30203151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting HMGB1/TLR4 axis and miR-21 by rosuvastatin: role in alleviating cholestatic liver injury in a rat model of bile duct ligation.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholestasis | Major topic |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | Major topic |
| Liver Diseases | Major topic |
| Rosuvastatin Calcium | Major topic |
| Animals | |
| Bile Ducts | |
| HMGB1 Protein | |
| Interleukin-6 | |
| Ligation | |
| Liver | |
| Male | |
| Malondialdehyde | |
| MicroRNAs | |
| NF-kappa B | |
| Rats, Wistar | |
| Toll-Like Receptor 4 | |
| Tumor Necrosis Factor-alpha |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25904867 | Oxidative stress-mediated HMGB1 biology. | Front Physiol | 2015 | https://conductscience.org/library/papers/25904867 | PubMed |
| 2 | 29229992 | miRNA-21 ablation protects against liver injury and necroptosis in cholestasis. | Cell Death Differ | 2018 | https://conductscience.org/library/papers/29229992 | PubMed |
| 3 | 23026026 | Hepatic expression of toll-like receptors 3, 4, and 9 in primary biliary cirrhosis and chronic hepatitis C. | Clin Res Hepatol Gastroenterol | 2012 | https://conductscience.org/library/papers/23026026 | PubMed |
| 4 | 16006099 | Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis. | J Autoimmun | 2005 | https://conductscience.org/library/papers/16006099 | PubMed |
| 5 | 24348775 | Postconditioning with rosuvastatin reduces myocardial ischemia-reperfusion injury by inhibiting high mobility group box 1 protein expression. | Exp Ther Med | 2014 | https://conductscience.org/library/papers/24348775 | PubMed |
| 6 | 22363424 | Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis. | PLoS One | 2012 | https://conductscience.org/library/papers/22363424 | PubMed |
| 7 | 28587864 | Up-regulation of circulating miRNA146a correlates with viral load via IRAK1 and TRAF6 in hepatitis C virus-infected patients. | Virus Res | 2017 | https://conductscience.org/library/papers/28587864 | PubMed |
| 8 | 24306421 | Emerging role of high-mobility group box 1 (HMGB1) in liver diseases. | Mol Med | 2013 | https://conductscience.org/library/papers/24306421 | PubMed |
| 9 | 15238821 | The antioxidant effects of statins. | Coron Artery Dis | 2004 | https://conductscience.org/library/papers/15238821 | PubMed |
| 10 | 23711603 | The role of HMGB1 in inflammation-mediated organ injury. | Acta Anaesthesiol Taiwan | 2013 | https://conductscience.org/library/papers/23711603 | PubMed |
| 11 | 24220159 | An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. | Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24220159 | PubMed |
| 12 | 26479335 | Therapeutic targets for cholestatic liver injury. | Expert Opin Ther Targets | 2016 | https://conductscience.org/library/papers/26479335 | PubMed |
| 13 | 23345947 | Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats. | World J Gastroenterol | 2013 | https://conductscience.org/library/papers/23345947 | PubMed |
| 14 | 25922659 | Activation of autophagy protects against cholestasis-induced hepatic injury. | Cell Biosci | 2014 | https://conductscience.org/library/papers/25922659 | PubMed |
| 15 | 22378043 | The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. | J Clin Invest | 2012 | https://conductscience.org/library/papers/22378043 | PubMed |
| 16 | 29029441 | Curcumin protects against hepatic ischemia/reperfusion induced injury through inhibiting TLR4/NF-κB pathway. | Oncotarget | 2017 | https://conductscience.org/library/papers/29029441 | PubMed |
| 17 | 21224055 | Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. | Am J Pathol | 2011 | https://conductscience.org/library/papers/21224055 | PubMed |
| 18 | 14578857 | Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. | Hepatology | 2003 | https://conductscience.org/library/papers/14578857 | PubMed |
| 19 | 25720799 | High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity. | Cancer Res | 2015 | https://conductscience.org/library/papers/25720799 | PubMed |
| 20 | 16301676 | Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. | J Immunol | 2005 | https://conductscience.org/library/papers/16301676 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40406577 | Dysregulated Hepatic Expression of Glucose Transporter Type-1, Toll-Like Receptor 4, and Nuclear Factor Kappa B in Estrogen-Induced Cholestasis Pregnant Rats with Placental Ischemia-Reperfusion Stress. | Matern Fetal Med | 2022 | https://conductscience.org/library/papers/40406577 | PubMed |
| 40190330 | Aloperin improves liver non-alcoholic steatohepatitis in vitro and in vivo. | Arch Med Sci | 2025 | https://conductscience.org/library/papers/40190330 | PubMed |
| 39349582 | Protective effects of cilostazol via the HNF1α/FXR signalling pathway and anti-apoptotic mechanisms in a rat model of estrogen-induced intrahepatic cholestasis. | Sci Rep | 2024 | https://conductscience.org/library/papers/39349582 | PubMed |
| 38357941 | Exploring the Potential Mechanisms of Action of Gentiana Veitchiorum Hemsl. Extract in the Treatment of Cholestasis using UPLC-MS/MS, Systematic Network Pharmacology, and Molecular Docking. | Comb Chem High Throughput Screen | 2024 | https://conductscience.org/library/papers/38357941 | PubMed |
| 38322817 | Papaverine attenuates the progression of alpha naphthylisothiocyanate induce cholestasis in rats. | Curr Res Pharmacol Drug Discov | 2024 | https://conductscience.org/library/papers/38322817 | PubMed |
| 37222533 | Rosuvastatin suppresses TNF-α-induced matrix catabolism, pyroptosis and senescence via the HMGB1/NF-κB signaling pathway in nucleus pulposus cells. | Acta Biochim Biophys Sin (Shanghai) | 2023 | https://conductscience.org/library/papers/37222533 | PubMed |
| 35624826 | 18β-Glycyrrhetinic Acid Protects against Cholestatic Liver Injury in Bile Duct-Ligated Rats. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35624826 | PubMed |
| 35578102 | Targeting the TLR4/NF-κΒ Axis and NLRP1/3 Inflammasomes by Rosuvastatin: A Role in Impeding Ovariectomy-Induced Cognitive Decline Neuropathology in Rats. | Mol Neurobiol | 2022 | https://conductscience.org/library/papers/35578102 | PubMed |
| 35335612 | From Inflammation to Fibrosis: Novel Insights into the Roles of High Mobility Group Protein Box 1 in Schistosome-Induced Liver Damage. | Pathogens | 2022 | https://conductscience.org/library/papers/35335612 | PubMed |
| 35196362 | Network pharmacology analysis and molecular docking to unveil the potential mechanisms of San-Huang-Chai-Zhu formula treating cholestasis. | PLoS One | 2022 | https://conductscience.org/library/papers/35196362 | PubMed |
| 34047945 | TLR4 Knockout Attenuates BDL-induced Liver Cholestatic Injury through Amino Acid and Choline Metabolic Pathways. | Curr Med Sci | 2021 | https://conductscience.org/library/papers/34047945 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| TLR4 | 7099 | PubTator's text mining | https://conductscience.org/library/genes/7099 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30203151
GET https://conductscience.org/api/papers/v1/30203151/references?page=2